Promising Results for Two Genetic Weapons Against Malaria
Antimalarial bacteria and immune-boosted mosquitoes show strong potential to spread in the wild
Two new papers by researchers at the Johns Hopkins Bloomberg School of Public Health’s Malaria Research Institute report successes for highly promising strategies against malaria, a disease that still kills more than 400,000 people each year, mostly children age five and under in sub-Saharan Africa.
The two studies discovered different ways by which resistance to the malaria parasite can spread into a mosquito population, potentially opening the way for the development of self-propagating malaria control strategies. The advantage of this feature is the lesser need to continuously apply malaria control measures such as insecticides and bed nets.
One team of researchers discovered a strain of bacteria that can spread rapidly and persist long-term among malaria-carrying mosquitoes. A genetically modified version of the bacterial strain strongly suppresses development of the malaria parasite, making the mosquitoes much less likely to transmit these parasites to humans.
A second research team discovered that a genetic modification that boosted the immune system of malaria-carrying mosquitoes not only suppresses malaria parasites in the insects but also can spread quickly in a test population, by changing the mosquitoes’ mating preferences.
Malaria is spread by female Anopheles mosquitoes carrying the malaria parasite. One promising way to prevent malaria, in addition to traditional approaches such as bed nets and insecticide, is to modify the mosquitoes so they are no longer capable of spreading the parasite to humans.
These new findings could lead to developing bacteria and mosquitoes that would be released into mosquito populations in the wild, and would propagate on their own to reduce malaria transmission to humans in endemic areas. These strategies are designed to be complementary and would be used in conjunction with things like bed nets and insecticides to diminish the transmission of disease.
The two papers appear in the September 29 issue of Science.
Bacteria vs. parasites
The discovery of the new mosquito-infecting bacterial strain was a chance event. “We were working with a different bacterium when a researcher on the project happened to find evidence of a bacterial colony in our mosquitoes’ ovaries,” says senior author Marcelo Jacobs-Lorena, a professor in the Bloomberg School’s Department of Molecular Microbiology and Immunology and a member of its Malaria Research Institute (JHMRI). “That was unusual—normally we find bacteria only in the mosquito gut.”
His team soon characterized these odd microbes as a strain of Serratia bacteria, and dubbed them Serratia AS1.
Jacobs-Lorena and other researchers have been developing genetically engineered bacteria that can infect mosquito populations and kill the malaria parasites the mosquitoes harbor, without harming the mosquitoes themselves. Getting such bacteria to spread efficiently has been a key challenge, but experiments revealed Serratia AS1 to be almost perfect for the task. Jacobs-Lorena and colleagues found that, unlike other mosquito-infecting bacteria, Serratia AS1 are easily transmitted from males to females during mating, and from female mosquitoes to their offspring. The bacteria also stably colonize the mosquito gut, where malaria parasites develop.
In one experiment, the scientists used Serratia AS1-laden sugar bait to infect males and virgin females representing just five percent of a mosquito test population, and found that in the next generation the bacterial strain was present in 100 percent of the larvae and adult mosquitoes. The researchers followed this mosquito population for two more generations—about a month’s time—and found that the bacteria remained ubiquitous. The results suggest that Serratia AS1 bacteria are likely to spread and persist long-term in wild mosquito populations.
The scientists modified Serratia AS1 by adding genes for five potent antimalarial proteins that were developed in the laboratory. Powered by these antimalarial proteins, the bacteria strongly inhibited malaria development in colonized mosquitoes, reducing the levels of an early stage form of the parasite (oocytes) by more than 90 percent compared to mosquitoes that didn’t contain the modified bacteria.
Further experiments showed that the modified Serratia AS1 bacteria don’t have a significant effect on mosquito lifespan or fertility. The modified bacteria also appear able to colonize the most common species of malaria-transmitting mosquitoes, while the antimalarial proteins secreted by the bacteria can suppress the most common species of malaria parasites.
“So far all indications are that these anti-malarial proteins are universally effective against malaria parasites, and the Serratia AS1 bacteria that carry them can go into any malaria-carrying mosquito species,” Jacobs-Lorena says.
He and his colleagues now plan to follow their small-scale laboratory experiments with larger-scale experiments at the Malaria Research Institute’s “Mosquito House” research facility in Macha, Zambia. After that, the scientists hope to be able to release Serratia AS1 bacteria in an isolated, island-like environment to study how the microbes spread among wild mosquitoes.
Antimalarial genes alter mate preference to spread quickly in mosquito populations
In the second study, a team led by George Dimopoulos, professor in the Bloomberg School’s Department of Molecular Microbiology and Immunology, made small modifications to the DNA of malaria-transmitting Anopheles mosquitoes to boost the activity of immune genes in the insects. The enhanced immunity made the mosquitoes more resistant to infection by malaria parasites, and thus less likely to transmit the parasites to humans.
That result was expected. What wasn’t expected was the unusually high efficiency with which the modified mosquitoes spread their genetic modification to ensuing generations in a mixed population of modified and unmodified, wild-type mosquitoes.
Investigating this surprising result, Dimopoulos and colleagues found that boosting the mosquitoes’ immune genes also boosted their defenses against bacteria, reducing the normal bacterial load and altering the normal mix of bacterial species in the mosquito intestine and reproductive organs. This change in the insect “microbiota” in turn led to a change in mating preferences, such that modified male mosquitoes began to prefer unmodified, wild-type females, while wild-type males began to prefer modified females.
“We believe that by changing the microbiota we’re changing the scent of modified mosquitoes—which in turn alters mating preference,” says Dimopoulos. “It’s the perfect change in mating preference in this case, because it maximizes the chances of producing genetically modified offspring when mosquitoes compete for mates.”
It’s important to note that the DNA modifications only involved an alteration of the mosquito’s own gene activity, and not the introduction of foreign genes. Other laboratories are developing a different method to release mosquito genetic modifications into test populations using complex “gene drive” DNA modifications. These essentially override the normal dynamics of inheritance to force new genes into nearly 100 percent of the offspring of mating mosquitoes. While potentially very promising, gene drives are still controversial because of their artificiality, complexity, and potential for long-term instability.
The findings from Dimopoulos and his colleagues show that even a subtle genetic modification that merely boosts the activity of existing genes can spread quickly into a mosquito population—without the need for a complex gene drive system. However, the two systems could also be combined to maximize the spread of malaria-resistant mosquitoes.
Dimopoulos’s modified mosquito population has now been living in a colony in his laboratory for more than seven years, and has retained its high level of resistance to malaria for all that time, without any apparent adverse side effects from the genetic modification. “These mosquitoes haven’t changed in terms of feeding behavior or any other things that could be of concern,” Dimopoulos says.
Dimopoulos and his colleagues now plan to study the effects of their genetic modifications in larger settings, such as the Institute’s Mosquito House in Zambia.
“Driving mosquito refractoriness to the malaria parasite with engineered symbiotic bacteria” was written by Sibao Wang, André L. A. Dos-Santos, Wei Huang, Kun Connie Liu, Mohammad Ali Oshaghi, Ge Wei, Peter Agre, and Marcelo Jacobs-Lorena. The study was supported by grants from the National Institute of Allergy and Infectious Diseases (AI 031478), the Strategic Priority Research Program of Chinese Academy of Sciences (XDB11010500), and the National Nature Science Foundation of China (31472044).
“Changes in the microbiota cause genetically modified Anopheles to spread in a population,” was written by Andrew Pike, Yuemei Dong, Nahid Borhani Dizaji, Anthony Gacita, Emmanuel F. Mongodin, and George Dimopoulos. The study was supported by a grant from the National Institute of Allergy and Infectious Diseases (AI061576).
The research was also supported by Bloomberg Philanthropies.
# # #
Media contacts for the Johns Hopkins Bloomberg School of Public Health: Barbara Benham at 410-614-6029 or bbenham1@jhu.edu and Susan Sperry at 410-955-6919 or ssperry1@jhu.edu.